Trial intelligence / Profile preview

Viola tablet for breast cancer-related fatigue

IRCT20220302054170N1Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of benzyl benzoate in cancer-related fatigue (CRF), sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2022; status: completed.

02

Drugs

benzyl benzoate
03

Conditions

cancer-related fatigue (CRF)

Beyond the preview

Go deeper on IRCT20220302054170N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220302054170N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call